Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of plasma expanders in healthy Japanese adult males
jRCT1080222611Completed
- Sponsor
- LSI Medience Corporation
- Start
- Sep 2014
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of hetastarch, dextran 40 and glycerol + fructose + sodium chloride (4 arms), sponsored by LSI Medience Corporation. Primary endpoints: Blood parameter changes after plasma expander administration and Detectable period of plasma expanders in blood and urine. Started Sep 2014; status: completed.
02
Drugs
hetastarchdextran 40glycerol + fructose + sodium chloride
Beyond the preview
Go deeper on jRCT1080222611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222611.